SCHEMBL5085568

SCHEMBL5085568

CCC(=O)N(CCc1c[nH]c2ccc(OC)cc12)C(C)=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.65
HTR1A P08908 6/20 0.63
MTNR1A P48039 6/20 0.62
HTR1D P28221 5/20 0.62
MTNR1B P49286 4/20 0.62
HTR1B P28222 4/20 0.62
CYP2D6 P10635 3/20 0.62
HTR2B P41595 3/20 0.62
CYP1A2 P05177 3/20 0.62
HTR2A P28223 3/20 0.62
HTR2C P28335 3/20 0.62
HTR7 P34969 3/20 0.62
HTR6 P50406 3/20 0.62
HTR1E P28566 2/20 0.62
HTR5A P47898 2/20 0.62
HTR4 Q13639 2/20 0.62
HTR3E A5X5Y0 1/20 0.62
HTR3B O95264 1/20 0.62
CYP2C9 P11712 1/20 0.62
HTR1F P30939 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5085972 0.93 KMT2A (0.65) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL4075720 0.92 KMT2A (0.72) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL466333 0.83 KMT2A (0.70) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL5144423 0.83 KMT2A (0.74) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL5227242 0.82 KMT2A (0.69) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL28414663 0.82 KMT2A (0.69) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL16058705 0.82 KMT2A (0.69) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL3689658 0.82 KMT2A (0.59) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL2577657 0.81 KMT2A (0.55) KMT2AHTR1AMTNR1AHTR1DMTNR1B
SCHEMBL5146979 0.81 KMT2A (0.66) KMT2AHTR1AMTNR1AHTR1DMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008035177-A2 COMBINATION OF MT1 AND MT2 MELATONIN RECEPTOR AGONISTS AND A NOREPINEPHRINE/DOPAMINE REUPTAKE INHIBITOR COPHARM (LU) 2008-03-27 WO disclosed